Responses
Clinical/translational cancer immunotherapy
Original research
Preclinical characterization and clinical translation of pharmacodynamic markers for MK-5890: a human CD27 activating antibody for cancer immunotherapy
Compose a Response to This Article
Other responses
No responses have been published for this article.